Pharming reports Q2 results

4 days ago 1
  • Pharming press release (NASDAQ:PHAR) (OTCPK:PHGUF): Q2 GAAP EPS of $0.006.
  • Revenue of $93.2M (+25.8% Y/Y).
  • Full-year 2025 total revenue guidance raised to $335 million - $350 million, up from prior $325 million - $340 million.
  • Overall cash and marketable securities

Recommended For You

More Trending News

Read Entire Article